Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-013679
Filing Date
2017-05-18
Accepted
2017-05-18 16:05:21
Documents
2
Period of Report
2017-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1607
2 EX-24 DOCUMENT attachment1.htm EX-24 5017
  Complete submission text file 0000899243-17-013679.txt   8135
Mailing Address ADELPHI PLAZA UPPER GEORGE'S STREET DUN LAOGHAIRE, CO. DUBLIN L2 A96 T927
Business Address ADELPHI PLAZA UPPER GEORGE'S STREET DUN LAOGHAIRE, CO. DUBLIN L2 A96 T927 011-353-1-236-2500
Prothena Corp plc (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Noonberg Sarah B. (Reporting) CIK: 0001706301 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35676 | Film No.: 17854961